Z86.012
Personal history of benign carcinoid tumor
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code Z86.012 refers to a patient's medical history of having had a benign carcinoid tumor. Carcinoid tumors are slow-growing, typically non-cancerous growths that can develop in various parts of the body, most commonly in the gastrointestinal tract or lungs. When a tumor is classified as benign, it means it does not invade nearby tissues or spread to distant parts of the body. This history is important for ongoing medical care and monitoring, as some carcinoid tumors can recur or cause related health issues.
Causes & Symptoms
Clinical Causes: Genetic factors that predispose to neuroendocrine cell growth Chronic inflammation or irritation in affected organs Hormonal or environmental influences, though specific causes are often unclear Family history of neuroendocrine tumors
Key Symptoms: Symptoms from carcinoid tumors can vary depending on the location and whether the tumor secretes hormones. In many cases, benign carcinoid tumors are asymptomatic and discovered incidentally during examinations for other conditions. When symptoms are present, they may include flushing, wheezing, diarrhea, or abdominal pain if the tumor secretes hormones. Localized symptoms such as a palpable mass or discomfort in the affected area.
Diagnostic & Treatment
Diagnosis Path: Diagnosing a benign carcinoid tumor involves a combination of medical history assessment, physical examination, and diagnostic tests. These might include:
Treatment Protocols: Treatment options for benign carcinoid tumors aim to remove or control the growth of the tumor and manage any hormonal symptoms. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is Z86.012 a billable ICD-10 code?
Yes, Z86.012 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z86.012?
Clinical documentation must specify the nature of Personal history of benign carcinoid tumor and any associated comorbidities for accurate reporting.
Cite this Clinical Reference